David Cohen is a Gastroenterology physician. ClinicalTrials.gov lists 9 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4300 Alton Rd
Ste 810
Miami Beach, FL 331402800
Telephone
305-674-5925Registry record last updated 25 Jun 2010.
Clinical trials
- Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering From Gender Dysphoria
Sponsor: Assistance Publique - Hôpitaux de Paris
- Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE
Sponsor: Cardiovascular Research Foundation, New York
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
46 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20258 payments
- Janssen Scientific Affairs, LLCProgram year20253 payments
- PFIZER INC.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
94.2%Proton pump inhibitor62.7%Omeprazole47%Pantoprazole Sodium40%Esomeprazole Magnesium8%Dexlansoprazole Dr3%Prevacid2%Lansoprazole2%Part D<11 patientsH2 blocker15.5%Famotidine100%Part D≥70 patients+ 5 more classes in this area
Nervous system
2.4%Opioid Agonist1.2%Hydromorphone Hcl100%Part D<11 patientsBenzodiazepine1.2%Alprazolam100%Part D<11 patientsAnti-infectives
2.2%Penicillins with extended spectrum1.2%Amoxicillin-Clavulanate Potass100%Part D≥13 patientsNucleoside and nucleotide reverse transcriptase inhibitors1%Vemlidy100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2008–2009 per NIH RePORTER. The latest:
- PRESCRIBING PSYCHOTROPIC DRUGS TO YOUTH: CULTURAL FACTORS IN PARENTAL ATTITUDES
Florida International University
FY2009$129,600R21MH084832 - PRESCRIBING PSYCHOTROPIC DRUGS TO YOUTH: CULTURAL FACTORS IN PARENTAL ATTITUDES
Florida International University
FY2008$223,650R21MH084832
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”